Wishlist: Olink analysis of plasma samples from cancer patients
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is forecasting a requirement for the cardiotoxicity biomarker analysis of plasma samples obtained from cancer patients who have been treated with anthracyclines. This project specifically involves the use of Olink analysis to examine these samples, falling under the North American Industry Classification System code 541720 for research and development in biotechnology. As this is currently listed as a forecast, a formal contracting officer has not yet been assigned. Interested parties can direct inquiries to the Nctr Acquisition Liaison. The initiative aims to leverage specialized proteomic analysis to better understand the cardiac impacts of chemotherapy treatments in oncology patients.
General Info
Place of Performance
USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
